BQ-610
BQ-610 is a selective antagonist of the endothelin A receptor (ETA receptor) . BQ-610 specifically blocks the ETA receptor, competitively inhibiting the binding of endothelin-1 (ET-1) (a vasoconstrictive peptide) to the receptor, thereby blocking the effects of ET-1 such as vascular smooth muscle contraction, cell mitosis, and inhibition of hormone secretion. BQ-610 significantly alleviates cerebral vasospasm in rabbits. BQ-610 blocks the bronchial epithelial and pulmonary vascular cell proliferation caused by cigarette smoke in rat models. BQ-610 can delay the natural luteal regression in the cow's uterus. BQ-610 can be used for research on vasospasm, abnormal cell proliferation, and reproductive endocrine disorders[1][2][3].
Product Specifications
UNSPSC
12352005
Target
Endothelin Receptor
Related Pathways
GPCR/G Protein
Field of Research
Endocrinology; Cardiovascular Disease
Smiles
O=C(O)[C@@H](CC1=CNC2=C1C=CC=C2)NC([C@@H](CC3=CN(C=O)C4=C3C=CC=C4)NC([C@H](CC(C)C)NC(N5CCCCCC5)=O)=O)=O
Molecular Formula
C36H44N6O6
Molecular Weight
656.77
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135446/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ETA
CAS Number
[141595-53-1]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
